Retinal Imaging Devices Market Size, Share| Report 2021, 2028

The retinal imaging devices market is projected to reach US$ 3.00 billion by 2028 from US$ 2.06 billion in 2021; it is estimated to grow at a CAGR of 5.6% during 2021–2028.

Retinal imaging is a technique that is used to analyze and diagnose the condition of a patient's retina. Retinal imaging devices (RID) use high-resolution imaging systems to capture inside pictures of an eye. The captured image helps Virtual Private Network (VSP) network doctors assess the health of the retina, which helps in the detection and management of eye and health conditions such as diabetes, glaucoma, and macular degeneration, amongst others.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Retinal Imaging Devices Market: Strategic Insights

Retinal Imaging Devices Market

• 
  CAGR (2021 - 2028)

  5.6%
• Market Size 2021
  US$ 2.06 Billion
• Market Size 2028
  US$ 3 Billion

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• Carl Zeiss Meditec
• Revenio Group Oyj
• Nikon Corporation
• Optomed
• Topcon Corporation
• Imagine Eyes
• Epipole Ltd
• Forus Health Pvt Ltd
• Eyenuk Inc

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Device Type

• Fluorescein Angiography
• Fundus Camera
• Optical Coherence Tomography

End-User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Specialized Eye Care Centers
• Other End Users

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

The growth of the retinal imaging devices market is attributed to the improved ophthalmologists’ access to the retina, growing global initiatives for blindness and technological advancements. However, the high cost of OCT devices hampers the market growth. 

Market Insights
Rising prevalence of eye diseases

Retinal imaging devices are widely used to diagnose and treat various eye-related diseases such as diabetic retinopathy, age-related macular degeneration, glaucoma, ocular melanoma, and mild vision problems. In addition, across the world, concern for blindness or vision impairment is growing significantly. According to the data published by the World Health Organization (WHO) in October 2021, nearly 2.2 billion people live with a vision impairment or blindness. Among which approximately one billion vision impairment cases can be prevented by proper diagnosis and treatment. These one billion people have different eye problems related to moderate or severe distance vision impairment or blindness. Image-related diagnostic technologies have begun to offer unprecedented growth into eye diseases based on morphological datasets. Such a factor is expected to aid the retinal imaging devices market over the forecast period.

Device Type-Based Insights

Based on device type, the global retinal imaging devices market has been segmented into fluorescein angiography, fundus camera, and optical coherence tomography. The fundus camera segment held the largest share of the market in 2021. Fundus photography has transformed from electronic flashes to smartphone-based cameras to a more recent portable eye examination kit (PEEK). PEEK is a smartphone-based application for a comprehensive eye examination. The advantage of these cameras is that a non-ophthalmologist can take pictures and, with some training, grade them as well. However, the optical coherence tomography segment is anticipated to register the highest CAGR of 8.1% in the market during the forecast period. The optical coherence tomography allows the evaluation of different levels of macular ischemia that are not diagnosed in primary imaging. The technique is used as a standard for imaging modalities for eyes.

End-User-Based Insights

Based on end-user, the global retinal imaging devices market is segmented into hospitals and clinics, specialty clinics, ambulatory care centers, and others. The hospitals & clinics segment held the largest share of the market in 2021 and specialized eye care centers is expected to register the highest CAGR of 6.6% in the market during the forecast period.

Retinal Imaging Devices Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

 

Regional Insights

Based on regions, the North America region accounted for the largest share in 2021 and is expected to follow a similar trend over the forecast period. The Asia Pacific region is expected to witness the highest growth rate over the forecast period. The application of Artificial intelligence (AI) and deep learning system (DLS) to improve screening coverage in Singapore is expected to assist the regional growth over the next seven years.

Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the retinal imaging devices market players focus on the partnership strategy to expand their clientele, which, in turn, permits them to maintain their brand name across the world.

Based on device type, the retinal imaging devices market is categorized into fluorescein angiography, fundus camera and optical coherence tomography. Based on end-user, the market is segmented into hospitals & clinics, ambulatory surgical centers, specialized eye care centers and other end users. By geography, the retinal imaging devices market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).Some of the company profiles listed in our research scope are Carl Zeiss Meditec, Revenio Group Oyj, Nikon Corporation, Optomed, Topcon Corporation, Imagine Eyes, Epipole Ltd, Forus Health Pvt Ltd, Eyenuk Inc, and Phoenix Technology Group LLC amongst others.